Kuijie decoction ameliorates ulcerative colitis by affecting intestinal barrier functions, gut microbiota, metabolic pathways and Treg/Th17 balance in mice

被引:12
作者
Peng, Kaixin [1 ]
Xia, Suhong [1 ]
Xiao, Siqi [1 ]
Zhang, Mingyu [1 ]
Liao, Jiazhi [1 ]
Yu, Qin [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastroenterol & Hepatol, Jiefang Ave 1095, Wuhan 430030, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Kuijie decoction; Ulcerative colitis; Gut microbiota; Microbial metabolites; Th17/Treg balance; IMMUNITY;
D O I
10.1016/j.jep.2023.117316
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Currently, the clinical treatment is limited and difficult to achieve satisfactory results for ulcerative colitis (UC). The role of traditional Chinese medicine (TCM) in the treatment of UC is very complex. Kuijie decoction (KJD) as a classic TCM, is widely used in the clinical treatment of UC, but the mechanism of its action is still unclear.Aim of the study: This study is to investigate the protective effects of KJD on UC and the underlying mechanisms. Materials and methods: The experimental model of UC was induced by DSS, and KJD was introduced into the model at the same time. Clinical symptoms, including the body weight, colon length and colon histopathological, were used to measure the severity of colitis. The expression of inflammatory cytokines and tight junction proteins was quantified. The effect of KJD on intestinal flora and intestinal metabolism was determined by 16S rRNA and untargeted metabolomics analysis, respectively. The proportion of Th17 cells and Tregs in the spleen was examined by flow cytometry.Results: Mice treated with KJD showed significantly alleviated clinical symptoms and histological damage, such as more body weight gain, lower disease activity index (DAI) score, and longer colon length. The administration of KJD also led to the down-regulation of inflammatory mediators, upregulation of the expression of ZO-1, occludin and decreased claudin-2, as well as altered microbiota composition against DSS challenges (especially an increase of Lachnospiraceae). KJD enhanced the percentage of Treg cells but decreased the proportion of Th17 cells to maintain intestinal homeostasis by improving gut microbiota metabolism. Conclusions: In summary, KJD maintained intestinal epithelial homeostasis by regulating epithelial barrier function, intestinal flora, and restoring Th17/Treg balance. KJD has the potential to be a Chinese medicine treatment for UC.
引用
收藏
页数:15
相关论文
共 62 条
  • [11] Efficacy and Safety of Sophora flavescens (Kushen) Based Traditional Chinese Medicine in the Treatment of Ulcerative Colitis: Clinical Evidence and Potential Mechanisms
    Chen, Mingjun
    Ding, Yuxuan
    Tong, Zhanqi
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [12] Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis A Randomized Clinical Trial
    Costello, Samuel P.
    Hughes, Patrick A.
    Waters, Oliver
    Bryant, Robert, V
    Vincent, Andrew D.
    Blatchford, Paul
    Katsikeros, Rosa
    Makanyanga, Jesica
    Campaniello, Melissa A.
    Mavrangelos, Chris
    Rosewarne, Carly P.
    Bickley, Chelsea
    Peters, Cian
    Schoeman, Mark N.
    Conlon, Michael A.
    Roberts-Thomson, Ian C.
    Andrews, Jane M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (02): : 156 - 164
  • [13] Experimental colonization with Blastocystis ST4 is associated with protective immune responses and modulation of gut microbiome in a DSS-induced colitis mouse model
    Deng, Lei
    Wojciech, Lukasz
    Png, Chin Wen
    Koh, Eileen Yiling
    Aung, Thet Tun
    Kioh, Dorinda Yan Qin
    Chan, Eric Chun Yong
    Malleret, Benoit
    Zhang, Yongliang
    Peng, Guangneng
    Gascoigne, Nicholas Robert John
    Tan, Kevin Shyong Wei
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (05)
  • [14] SLC26A3 (DRA) prevents TNF-alpha-induced barrier dysfunction and dextran sulfate sodium-induced acute colitis
    Ding, Xiangming
    Li, Dongxiao
    Li, Mengke
    Wang, Han
    He, Qin
    Wang, Yunwu
    Yu, Hongbing
    Tian, Dean
    Yu, Qin
    [J]. LABORATORY INVESTIGATION, 2018, 98 (04) : 462 - 476
  • [15] Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients
    Goeters, C
    Wenn, A
    Mertes, N
    Wempe, C
    Van Aken, H
    Stehle, P
    Bone, HG
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (09) : 2032 - 2037
  • [16] Flos Sophorae Immaturus: Phytochemistry, bioactivities, and its potential applications
    Gong, Yuhong
    Fan, Liuping
    Wang, Li
    Li, Jinwei
    [J]. FOOD REVIEWS INTERNATIONAL, 2023, 39 (06) : 3185 - 3203
  • [17] The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
    He, Long
    Wen, Shuting
    Zhong, Zhuotai
    Weng, Senhui
    Jiang, Qilong
    Mi, Hong
    Liu, Fengbin
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [18] Relationship between clinical features and intestinal microbiota in Chinese patients with ulcerative colitis
    He, Xu-Xia
    Li, Ying-He
    Yan, Peng-Guang
    Meng, Xiang-Chen
    Chen, Chu-Yan
    Li, Ke-Min
    Li, Jing-Nan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (28) : 4722 - 4737
  • [19] Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution
    Heller, F
    Florian, P
    Bojarski, C
    Richter, J
    Christ, M
    Hillenbrand, B
    Mankertz, J
    Gitter, AH
    Bürgel, N
    Fromm, M
    Zeitz, M
    Fuss, I
    Strober, W
    Schulzke, JD
    [J]. GASTROENTEROLOGY, 2005, 129 (02) : 550 - 564
  • [20] New Therapeutics for Ulcerative Colitis
    Hirten, Robert P.
    Sands, Bruce E.
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 72, 2021, 2021, 72 : 199 - 213